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AbstrAct
Introduction Within England the removal of 
prescribed gluten-free (GF) foods from many 
Clinical Commissioning Groups has resulted 
in a greater reliance on commercially available 
GF food by adults and children with coeliac 
disease (CD). High cost and limited availability 
of GF foods are associated with poorer dietary 
adherence in people with CD.
Aim To assess if the rise in popularity of GF diets 
globally has improved the cost or availability of 
cereal-based GF foods over the past 6 years.
Design Observational study where data were 
collected on cereal-based GF foods from 50 
stores and 10 internet retailers. The number of 
GF foods within each food category and the 
cost per 100 g of GF and gluten-containing (GC) 
foods were compared by store type.
Results GF food availability has increased 
in premium stores and online. The majority 
(82%) of GF food categories were significantly 
more expensive online compared with regular 
supermarkets. On average, GF breads were 
400% more expensive compared with GC breads 
(p<0.001); no narrowing in cost difference over 
time observed. Convenience stores did not stock 
any GF bread nor GF pasta and only one of the 
budget supermarkets stocked them, similar to 
data reported 6 years ago.
Conclusions GF food availability has increased, 
predominately in premium markets. The GF food 
desert within convenience and budget stores 
will continue to disproportionately impact poor 
socioeconomic cohorts, the elderly and physically 
disabled. A lack of accessibility to GF foods 
impacts GF dietary adherence, increasing related 
comorbidities and healthcare costs.
IntroductIon
Coeliac disease is an autoimmune enterop-
athy caused by genetic and environmental 
factors, where the ingestion of gluten 
causes damage to intestinal mucosa with 
resultant impaired nutrient absorption, 
and increased risk of anaemia and osteo-
porosis.1 Worldwide prevalence of coeliac 
disease is estimated at 1.4%.2 Presently 
there is no cure and coeliac disease is 
managed by patients adhering to a life-
long, strict gluten-free (GF) diet. Gluten 
is a protein within wheat, barley and rye; 
thus a GF diet excludes many commonly 
consumed carbohydrate-based foods and 
includes alternatives such as manufactured 
GF bread, GF flour and GF pasta, as well 
as naturally occurring GF foods such as 
potatoes and rice. Adhering to a GF diet 
can be very challenging, it requires knowl-
edge, skills and modified behaviours 
to undertake the substantial changes to 
dietary habits.3 Studies have reported the 
proportion of people with coeliac disease 
who adhere to a GF diet ranges from 36% 
to 96% depending on the methodology 
used to determine dietary adherence 
and population recruited.4 Improving 
GF dietary adherence is key to reducing 
morbidity associated with coeliac disease 
and associated healthcare costs.5
The increasing trend for grocery shop-
ping online has enabled people with 
coeliac disease to access GF foods via 
internet food delivery services and global 
sales of GF foods have substantially 
increased in recent years.6 Influencing 
this is the rise in popularity of consuming 
GF foods for gluten sensitivity and GF 
living as a lifestyle choice contributing to 
consumer demand for greater availability 
of GF foods.7 It is reasonable to postulate 
that there has been a substantial improve-
ment in the availability of manufactured 
GF foods within the UK, a viewpoint held 
by Clinical Commissioning Groups,8 and 
costs may also be reducing.
Within the UK, GF foods have been 
available through prescriptions since 
the 1960s to promote adherence by 
improving access to GF foods and reduce 
 o
n
 19 O
ctober 2018 by guest. Protected by copyright.
http://fg.bmj.com/
Frontline G
astroenterol: first published as 10.1136/flgastro-2018-101088 on 15 O
ctober 2018. Downloaded from
 
Jeanes YM, Hanci O. Frontline Gastroenterology 2018;0:1–7. doi:10.1136/flgastro-2018-1010882
SMall bOwel and nutritiOn
the financial burden to patients; this is still in line with 
today’s national guidance.9 10 However, in reality, 
access to prescribed GF foods is very variable across 
the UK, in several areas prescribed GF foods are not 
available to patients.11
The economic burden of the GF diet and the limited 
availability of GF foods12 13 can impact on patients’ 
quality of life14 15 and GF dietary adherence.16 17 The 
current study aims to assess if the rise in popularity of 
GF diets globally has improved the cost or availability 
of commercially available cereal-based GF foods over 
the past 6 years.
MAterIAls And Methods
A cross-sectional survey of manufactured GF foods 
was conducted in 2017. Data were collected from two 
areas within London with dipolar opposite deprivation 
indices, to reduce any bias this may cause. 
Food retailers
Fifty physical stores were surveyed, inclusive of 
premium, regular and budget supermarkets, health 
food and convenience stores; stores were categorised 
as previously described.12 Supermarkets, between each 
category, were selected to be of similar size to account 
for difference in stock availability between varying 
store size. An internet search identified physical food 
stores; the stores selected represented geographical 
spread for each region in order to account for differ-
ences in local population. Permission to collect data 
was obtained from the duty or store manager. Online 
retailers of manufactured GF foods were identi-
fied through extensive UK-based internet searches 
and information from Coeliac UK, 10 retailers were 
selected, 5 were affiliated with a physical supermarket 
surveyed and 5 were independent online retailers 
providing GF food delivery.
Food categories
Eleven cereal-based food categories were surveyed; 
white and brown bread loaves, white and brown 
bread rolls, flaked breakfast cereals, pasta, plain flour, 
crackers and crispbreads, cereal bars, sweet biscuits and 
whole sponge cake. In addition, sandwiches/wrap and 
GF oats were included. The selected food categories 
include those within the Coeliac UK’s ‘Gluten Free 
Guarantee’ campaign.18
Procedure
Each store was systematically explored, the total 
number of GF and gluten-containing (GC) food prod-
ucts available for each food category was recorded 
per store. The GF foods were confirmed to be so, by 
having the Crossed Grain symbol on their packaging 
or when the symbol was not available the ingredients 
were examined, those which contained wheat, barley, 
rye, oats, spelt, Khorasan wheat/kamut were excluded. 
Labels which stated ‘may contain traces of gluten’, 
‘made on a line handling wheat’, ‘made in factory 
also handling wheat’ and ‘not suitable for people with 
coeliac disease/a wheat allergy due to manufacturing 
methods’ were also excluded. Information on weight, 
pack size and price was recorded for the cheapest and 
most expensive GF and GC cereal-based food prod-
ucts in physical stores. The cost was recorded as pence 
sterling per 100 g. At the time of data collection, the 
exchange rate was £100=US$1.3=€1.18. The mean 
value from the cheapest and the most expensive GF 
food product for each food category listed and their 
GC counterparts was calculated for each store, where 
only one option was available this value was used, as 
published previously to allow for comparisons over 
time.12 Costs recorded were exclusive of any delivery 
cost associated with purchase.
statistical analysis
Continuous data were assessed for normality using 
Kolmogorov-Smirnov. Data are presented as median 
values (IQR) unless stated otherwise. Continuous 
non-parametric data analysis used the Kruskal-Wallis 
and Mann-Whitney U tests to examine differences in 
availability and cost of GF foods across all retailer 
categories. A p value of <0.05 was considered signifi-
cant and all values were two sided. Data were analysed 
using SPSS, V.21 (IBM). There were no significant 
differences between the two regions surveyed (data 
not shown), data from the two regions are presented 
combined.
results
Availability of manufactured GF foods
None of the convenience stores and only one of 
budget supermarkets stocked any of the GF food cate-
gories surveyed (table 1). Food staples: GF breads, 
GF pasta and GF flour were available in all online 
stores, premium and regular supermarkets, however, 
none of the convenience stores stocked any GF food 
staples and only 10% of budget supermarkets stocked 
GF bread and GF pasta (table 1). An increase in the 
availability of GF bread loaves was observed within 
premium and regular supermarkets from an average 
of 3 and 5 loaves in 2011 to 12 and 7 loaves respec-
tively in the current study.12 Additionally, compared 
with data published in 2011 we report a greater 
availability of GF pasta and GF sweet biscuits and a 
similar availability of GF plain flour, GF bread rolls 
and GF whole sponge cakes in premium and regular 
supermarkets.12 No increase in average availability of 
GF foods from budget nor convenience stores was 
observed; online data were not reported in 2011. GF 
sandwich/wrap availability was particularly poor with 
only two regular supermarkets stocking them (one 
option in each store), none of the other physical stores 
and online stores stocked any GF ready-made sand-
wiches/wraps (table 1).
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cost of manufactured GF foods
GF foods were significantly more expensive than their 
GC counterparts in 91% of the food categories; in 
particular GF bread loaves were substantially more 
expensive (400%), similar to the 360% published in 
201112 (table 2). GF bread rolls were 379% more 
expensive compared with just 155% in 201112 
(table 2). However, the percentage difference does 
appear to have narrowed over time between GF and 
GC pasta, crackers, sweet biscuits and cake (table 2). 
The 85% higher cost of GF flour compared with GC 
flour is lower than the 184% reported in 2011.12 Our 
data do include large variation between stores, as 
demonstrated by the large IQR values for percentage 
difference values in regular and premium supermarkets 
(table 3). Eighty-two per cent of GF food categories 
were more expensive online compared with regular 
supermarkets (table 3). Independent online food stores 
stocked significantly more expensive GF versions of all 
types of bread, flaked breakfast cereal and plain flour 
(p<0.05) when compared with supermarket-affiliated 
online food stores. The percentage difference in cost 
between GF and GC foods is greater in regular super-
markets compared with premium supermarkets in 
five food categories (table 3), in particular GF brown 
loaves are 400% more expensive in regular supermar-
kets compared with 255% in premium supermarkets 
(p=0.014, table 3).
dIscussIon
The scarcity of manufactured GF foods within budget 
and convenience stores persists. A clear positive is the 
larger range available within online stores, regular 
and premium supermarkets compared with previous 
reports.12 13 Online stores have the potential to greatly 
improve access to GF foods, however, it is noteworthy 
that the majority of GF foods within online stores 
were more expensive than those within physical stores. 
Contemporary barriers exist to accessing GF food 
from online stores, such as poor access to the internet, 
costs associated with being online and poor digital 
literacy; these disproportionately impact those soci-
oeconomically disadvantaged, of poor literacy, rural 
communities, those with disabilities and include the 
older generation.19 20 The distinction between availa-
bility and accessibility must be considered; improving 
geographical availability to those who can least afford 
it, at costs which are unapproachable, does not equate 
to accessibility. This is an area for further research to 
investigate the accessibility of GF foods for all popula-
tion groups of people with coeliac disease.
None of the convenience stores and only one budget 
store stocked any of the surveyed GF foods, a situa-
tion that has not improved in recent years.12 13 This is 
especially significant for populations who are reliant 
on convenience stores and budget supermarkets as 
their main food source, such as the socioeconomically 
disadvantaged, those affected by poor levels of car 
ownership, the isolated elderly and those with physical 
disabilities.21 22 Of relevance, a recent study revealed 
South Asian patients with CD were unable to find 
GF foods in their local Asian food stores.23 Pharma-
cies, through prescriptions, can double the locations 
where GF foods are sourced.24 Receiving GF foods on 
prescription is associated with better GF dietary adher-
ence scores,25 possibly by improving the economic 
burden and accessibility issues for some patients. The 
large variation in GF prescribing practices within 
England, with an overall trend in reducing amounts 
of GF foods prescribed,26 will further impact on the 
availability of GF foods. Both the availability and cost 
of GF foods have previously been shown to impact on 
patients’ quality of life and GF dietary adherence.14–17 
Even with prescriptions in place, as in parts of the UK, 
the financial burden on an individual diagnosed with 
Table 2 Comparison of cost between gluten-free (GF) and gluten-containing (GC) foods
Product n* Gluten-free cost†
(pence/100 g)
Gluten-containing cost† 
(pence/100 g)
P values % Difference‡
2017†
% Difference 201112
All bread loaves 37 64 (55–68) 13 (10–23) <0.001 400 (187–490) 360
White loaf 20 61 (55–67) 12 (9–29) <0.001 467 (218–500) –
Brown loaf 17 66 (55–72) 17 (11–23) <0.001 324 (187–404) – 
All bread rolls 37 90 (70–96) 18 (13–27) <0.001 379 (281–491) 155
White bread rolls 20 90 (67–92) 18 (13–27) <0.001 384 (236–403) – 
Brown bread rolls 17 96 (78–103) 18 (12–27) <0.001 386 (281–536) – 
Cereals—flaked 15 85 (67–92) 44 (33–44) <0.001 109 (52–149) 96§
Cereal bars 20 176 (153–193) 132 (129–140) 0.001 30 (6–46) – 
Pasta 20 41 (34–59) 28.5 (21–66) 0.1 18 (−12 to 70) 175
Plain flour 20 18 (17–35) 9.5 (5–43) 0.006 85 (−5 to 269) 184
Crackers/crispbreads 20 160 (114–243) 85 (69–109) <0.001 122 (79–124) 220
Sweet biscuits 15 130 (103–139) 63 (62–66) <0.001 107 (77–130) 518
Whole sponge cake 15 83 (80–85) 60 (48–67) <0.001 35 (24–46) 78
*Number of stores that stocked a GF and GC version of the food. Median (IQR) costs are presented for each food category from premium and regular supermarkets combined. 
†Cost for each food category, for each individual supermarket, was calculated as a mean value between the cheapest and most expensive item; the median (IQR) was then calculated for all premium 
and regular supermarkets combined. 
‡% Difference between cost of GF and GC food categories. 
§Includes all GF breakfast cereals. 2011 data presented as mean values.
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CD can be significant, adding an average of £861 to 
food shopping costs over a year.27 Our study reports 
GF breads continue to be significantly more expensive 
than their GC counterparts. The exceptionally high 
comparative cost of GF breads has been consistently 
reported.12 13 28 GF breads require alternative grains 
and complex manufacturing processes in order to 
provide a palatable, nutritionally adequate product, 
which together incur additional expense. We also 
report a greater percentage difference in costs between 
GF and GC breads in regular compared with premium 
supermarkets; key when taking into consideration the 
largely absent GF foods in budget supermarkets, thus 
impacting on those with the smallest food budgets 
greatest. There appears to be a narrowing in cost 
difference for GF compared with GC flour, pasta and 
biscuits which is encouraging to see. A strength of our 
study is only including cost values from stores where 
GF and GC foods were available, eliminating store-
type bias. Our study does have limitations, our physical 
store data are from a single city and do not necessarily 
reflect the rest of the country or other countries. Our 
study focused on cereal-based GF foods, it is outside 
the scope of this study to extrapolate the findings 
towards the GF diet, which comprised foods naturally 
GF, prescribed GF foods and other non-cereal-based 
GF foods (eg, sauces and sausages).
There are very limited data from the UK exploring 
the impact of reduced access to prescribed GF foods 
with a greater reliance on commercially available 
sources. A situation has developed where people with 
coeliac disease from lower socioeconomic groups 
are at risk of not being able to afford GF foods, thus 
impacting their ability to adhere to the GF diet and 
potentially leading to coeliac disease-related morbidity 
and additional healthcare costs.1 Longitudinal studies 
are needed to assess the impact of policy changes in GF 
prescribing on dietary adherence and inclusive of data 
on morbidity associated with gluten consumption.
conclusIons
Although GF food availability has increased, this is 
predominantly in the premium markets. The GF food 
desert within convenience stores and budget super-
markets will continue to disproportionately impact 
poor socioeconomic cohorts, the elderly and physi-
cally disabled. Additional barriers exist when accessing 
GF foods from online stores. The growth of the GF 
food market in recent years has not led to the antici-
pated transformation in accessibility of manufactured 
GF foods nor reduced the price of GF staple foods. 
Research is needed to accurately assess the current 
and real-life economic burden of undertaking a life-
long GF diet in a diverse population of people with 
coeliac disease. Our study findings highlight subpop-
ulation groups are likely to have higher treatment 
burden from a GF diet, this is important to highlight to 
policymakers, and inform the conversations between 
healthcare professionals and people with coeliac 
disease.
significant of this study
What is already known on this topic
 ► Lifelong, strict adherence to a gluten-free diet is 
the only treatment for coeliac disease. The rise in 
popularity of gluten-free foods and the reduction 
in prescribed gluten-free foods has increased the 
demand for commercially available gluten-free foods.
What this study adds
 ► The growth of the gluten-free food market in recent 
years has not led to the anticipated transformation 
in accessibility of commercially available gluten-free 
foods. Gluten-free foods are scarcely available in 
budget and convenience stores and their high cost 
persists. The treatment burden disproportionally 
impacts poor socioeconomic cohorts, the elderly and 
physically disabled.
How might it impact on clinical practice in the 
foreseeable future
 ► The study aims to inform policymakers when 
considering gluten-free prescribing by highlighting the 
need to consider all population groups with coeliac 
disease. It will inform the conversations between 
healthcare professionals and patients with coeliac 
disease, by increasing awareness of the economic 
burden and access issues when adhering to the 
gluten-free diet.
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